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Objective: Little information is available about surgical outcomes in patients with multivalvular endocarditis.
The aim of this article is to review the 21-year experience with surgical treatment of patients with multivalvular
endocarditis at our institution and, in particular, to determine the incidence, pathologic status, diagnosis, surgical
strategies, and outcomes of patients with this disease.
Methods: From January 1986 to December 2006, a total of 48 patients (40 men, 8 women), with a mean age of 42
 12 years, underwent surgery for multivalvular endocarditis. Endocarditis was active in 32 patients and healed in
16. Preoperative transthoracic echocardiographic evaluation was performed in all 48 patients with addition of
transesophageal echocardiography in 22 (45.8%). Intraoperative findings showed that the endocarditis involved
mostly the mitral and aortic valves (40/48 patients). Triple or quadruple valve involvement was found in 1 and 2
patients, respectively. Preoperative, perioperative, and postoperative data were retrospectively analyzed and risk
factors for early and late survival were determined.
Results: In only 24 (50.0%) patients was multivalvular endocarditis diagnosed by preoperative transthoracic
echocardiography; 17 (77.3%) patients had multivalvular endocarditis confirmed by preoperative transesopha-
geal echocardiography. The 30-day hospital mortality was 12.5% (n ¼ 6). Preoperative renal failure, New
York Heart Association class IV, and emergency surgery were identified as independent risk factors for hospital
mortality. Overall long-term survival was 74% 6% at 5 years and 62% 3% at 10 years. Multivariate analysis
revealed that renal failure and recurrent endocarditis were associated with increased late mortality. Ten-year free-
dom from recurrent endocarditis was 74%  5% and 10-year freedom from reoperation was 73%  6%.
Conclusions: In our institution, multivalvular endocarditis was diagnosed by transthoracic echocardiography in
only half of the patients. Intraoperative transesophageal echocardiography provided a more effective means to
identify this disease. Radical resection of all infected tissues for patients with multivalvular endocarditis and ad-
ditional intraoperative interventions, depending on the intraoperative pathologic condition, produced satisfactory
in-hospital and long-term results, similar to those in patients with a single infected heart valve.Even though great improvements have been made in general
health care and antibiotic therapy, the incidence of infective
endocarditis has not changed during the past decades.1 De-
spite dramatic improvements in the natural history of infec-
tive endocarditis after the introduction of antimicrobial
therapy,2 this entity remains a serious disease that requires
surgical intervention in up to 20% to 40% of affected pa-
tients.3,4 Surgical treatment of native valve endocarditis
(NVE) involving a single valve is well documented, with ex-
cellent results reported with both valve repair and replace-
ment.5 However, little information is available concerning
patients with multivalvular endocarditis (MVE) that affects
simultaneously at least two cardiac valves. Current under-
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ports6-9 and not on systematic retrospective investigation.
The purpose of this study was to review the 21-year experi-
ence with surgical treatment of patients with MVE at our
institution and, in particular, to determine the incidence,
pathologic status, diagnosis, surgical strategies, and short-
term and long-term surgical results of patients with MVE.
PATIENTS AND METHODS
A review of the cardiac surgery database of Shanghai Changhai Hos-
pital (a 1000-bed tertiary care teaching hospital in southeast China with
approximately 1200 cardiac operations performed in 2006) disclosed
388 patients who had surgery for NVE from January 1986 to December
2006. A total of 48 patients (40 men, 8 women), with a mean age of 42
 12 years, underwent surgery for MVE. The review of these patients
was approved by our institutional committee for human research. In pa-
tients with preoperative echocardiograms, the diagnosis of MVE was
made using the Duke criteria.10 Endocarditis was considered to be active
if the patient had positive blood cultures, operative findings of acute in-
flammation, or positive cultures or Gram stain of excised tissue. Endocar-
ditis was considered to be healed if the operation occurred more than 6
weeks after the initial diagnosis, a course of antibiotics was completed,
blood cultures were negative at the time of the operation, and cultures
and Gram stains of intraoperatively excised tissue were negative. Charac-
teristics of the patients are detailed in Table 1. Endocarditis was active in
32 patients and healed in 16 patients. Probable sources of infection wereardiovascular Surgery c Volume 137, Number 6 1475
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CHD ¼ congenital heart disease
CI ¼ confidence interval
MVE ¼ multivalvular endocarditis
NVE ¼ native valve endocarditis
OR ¼ odds ratio
TEE ¼ transesophageal echocardiography
TTE ¼ transthoracic echocardiography
identified in 11 patients, with 5 infections attributed to dental sources. Pre-
disposing factors were found in 31 patients, with rheumatic heart valve dis-
ease in 18, degenerative heart valve disease in 6, and congenital heart
disease (CHD) in 17. Information regarding the offending microorganism
was available in 31 patients and is shown in Table 2. Streptococcus viridans
was the most common microorganism, which occurred in 29.1% of the pa-
tients, followed by Staphylococcus infection (18.7%) and Enterococcus
infection (4.2%). Preoperative transthoracic echocardiographic (TTE) eval-
uation was performed in all patients and transesophageal echocardiography
(TEE) was also performed in 22 patients (45.8%, Table 3). Coronary angi-
ography was performed in most patients older than 50 years and in those
with suspected coronary artery disease except if they had large vegetations
near the coronary artery orifices.
Operative Technique
The primary indication for operation was congestive heart failure in
75% of patients. Other manifestations of endocarditis included persistent
sepsis (22.9%) and systemic emboli (27.1%). Operation was performed
electively in 47.9% and urgently or as an emergency in 52.1% (Table
1). All operations were carried out through a median sternotomy incision
with moderate hypothermia during cardiopulmonary bypass. Myocardial
protection was provided by the infusion of cardioplegic solution and top-
ical cooling. Radical resection of all infected valvular and paravalvular tis-
sues was the basic operative principle used in all patients. If the infection
was limited to the leaflets of the valve, simple valve repair or replacement
was performed. If the infection extended to the annulus or surrounding
structures, a radical resection of the abscess and patch reconstruction of
the annulus and adjoining structures was accomplished with either fresh
autologous pericardium or glutaraldehyde-fixed bovine pericardium. Six
attending surgeons performed the 48 operations. Table 4 summarizes the
operative information. In 20% of patients with mitral and aortic valve in-
volvement, mitral valve repair was performed, as has become increasingly
common in recent years. A variety of mitral repair techniques were used,
with pericardial patch repair of the anterior mitral leaflet being the most
commonly applied technique. In recent years, allografts were implanted
in the aortic position, and they have become the prosthesis of choice for
the management of the aortic valve infection. For tricuspid or pulmonary
valve endocarditis, our surgical principle is to repair the valve whenever
possible or use a biological substitute without any artificial material that
might become infected if valve replacement is inevitable.
Follow-up
Patients who had combined aortic valve replacement with mitral valve
repair and those who had a triple or quadruple valve operation were fol-
lowed up prospectively at annual intervals. The remaining patients were fol-
lowed up irregularly up to 2006, but all patients were contacted in the first 5
months of 2007. Follow-up was completed by telephone contact with the
patient, by analysis of standardized questionnaires that were mailed to the
patients, by analyzing the population registry, or by contacting peripheral
hospitals. The follow-up for this report was closed on June 1, 2007, and1476 The Journal of Thoracic and Cardiovascular SuTABLE 1. Patient characteristics
Characteristics
Total
(n ¼ 48)
Active MVE
(n ¼ 32)
Healed MVE
(n ¼ 16)
Mean age  SD, y 42  12 48  13 37  14
Male gender 40 29 11
No. of patients
in different decades
1980s 2 2 0
1990s 21 12 9
2000s 25 18 7
Predisposing factors
Rheumatic heart
valve disease
18 11 7
Degenerated heart
valve disease
6 4 2
Congenital heart
disease:
17 14 3
VSD 5 4 1
VSD and Valsalva
aneurysm
2 1 1
ASD 1 1 0
PDA 2 2 0
DCRVþPS 1 1 0
TOF 1 0 1
Bicuspid aortic
valve disease
5 5 0
Sites of infection
MV and AV 40 27 13
AV and TV 1 0 1
AV and PV 2 0 2
PV and TV 2 2 0
MV, AV, and PV 1 1 0
MV, AV, PV, and TV 2 2 0
NYHA functional class
II 7 2 5
III 19 15 4
IV 22 15 7
Electrocardiogram
Sinus rhythm 32 21 11
Atrial fibrillation 15 10 5
Complete heart block 1 1 0
Associated diseases
Diabetes mellitus 4 3 1
Hypertension 6 5 1
Chronic obstructive
lung disease
2 1 1
Renal insufficiency
(Cr 2.0 mg/dL)
8 7 1
Recent TIA/stroke 8 6 2
Cardiogenic/septic shock 2 2 0
Coronary artery disease 2 1 1
Left ventricular
ejection fraction<40%
5 2 3
Timing of operation
Same hospitalization 23 10 13
Urgent/emergency 25 22 3rgery c June 2009
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years (mean, 6.7 years), and the total cumulative follow-up was 348.4
patient-years. In 64.6% of patients, follow-up exceeded 5 years, and in
22.9% it exceeded 10 years.
Statistical Analysis
Descriptive statistics are reported as mean standard deviation for con-
tinuous variables and as frequencies and percentages for categorical vari-
ables. Risk factors for early mortality analysis were performed by the c2
test, Fisher’s exact test, and a multivariate logistic regression model.
Long-term survival or freedom from morbid events was evaluated by uni-
variate analysis with the log–rank test, and the stepwise Cox proportional
hazards approach was used to develop a multivariable model. The variables
with P<.1 on univariate analysis were entered into a multivariable analysis.
Survival curves were described by the Kaplan–Meier method. Statistical
analyses were performed on a personal computer using SAS 8.1 software
for Windows (SAS Institute, Cary, NC).
RESULTS
In our patient population, endocarditis affecting multiple
valves accounted for 12.4% of all patients with endocarditis
operated on at our institution. MVE was confirmed in all
patients with intraoperative findings and pathologic exami-
nation, whereas only 24 (50.0%) cases of MVE were diag-
nosed by preoperative TTE and 17 (35.4%) additional cases
were confirmed by preoperative TEE (Table 3).
We are following the recommendations of the most recent
guidelines to report mortality and morbidity.11 There were 6
(12.5%) operative deaths. The causes of death were often
multifactorial, but the main reasons were septic shock in 1
patient, low cardiac output syndrome in 1 patient, renal fail-
ure in 2 patients, multiorgan failure in 1 patient, and cerebral
TABLE 1. Continued
Characteristics
Total
(n ¼ 48)
Active MVE
(n ¼ 32)
Healed MVE
(n ¼ 16)
Surgical indications
Congestive heart failure 36 27 9
Sepsis 11 11 0
Emboli 13 9 4
MVE,Multivalvular endocarditis; SD, standard deviation; VSD, ventricular septal de-
fect; ASD, atrial septal defect; PDA, patent ductus arteriosus; DCRVþ PS, double-
chambered right ventricle and pulmonary valve stenosis; TOF, tetralogy of Fallot;
MV, mitral valve; AV, aortic valve; TV, tricuspid valve; PV, pulmonary valve;
NYHA, New York Heart Association; Cr, serum creatinine; TIA, transient ischemic
attack.
TABLE 2. Offending microorganisms
Microorganisms No. of patients
Streptococcus viridans 14 (29.1)
Other streptococci 2 (4.2)
Staphylococcus aureus 7 (14.5)
Staphylococcus epidermidis 2 (4.2)
Enterococcus faecalis 2 (4.2)
Other bacteria 4 (8.4)
Culture-negative endocarditis 17 (35.4)
Percentages are shown in parentheses.The Journal of Thoracic and Cembolism in 1 patient. Logistic regression analysis identified
preoperative renal failure (odds ratio [OR] 5.9, 95% confi-
dence interval [CI] 3.3–8.6), New York Heart Association
class IV (OR 2.7, 95% CI 1.3–4.0), and emergency surgery
(OR 2.5, 95% CI 1.2–4.4) as predictors of operative death.
Postoperative complications were common: 4 patients
had respiratory insufficiency, 2 patients required re-explora-
tion for bleeding and/or tamponade, 1 patient required inser-
tion of a permanent pacemaker for heart block, and 2
required hemodialysis for new postoperative renal failure.
Twelve patients died during the follow-up period. The
causes of late deaths were cardiac related in 4 (congestive
heart failure in 3 and myocardial infarction in 1), valve re-
lated in 6 (1 caused by structural valve deterioration and 5
caused by recurrent endocarditis), and other causes in 2 (can-
cer in 1 and diabetes in 1). Overall long-term survival was
74% 6% at 5 years and 62% 3% at 10 years (Figure 1).
Cox regression analysis identified the presence of renal fail-
ure (hazard ratio ¼ 2.7, 95% CI 1.3–5.6) and recurrent
endocarditis (hazard ratio¼ 1.9, 95% CI 1.5–3.2) as predic-
tors of late death.
Recurrent endocarditis occurred in 9 patients: 2 during the
first postoperative year and 7 in subsequent years. Of the 9
patients with recurrent endocarditis, 5 had involvement of
multiple valves and 4 had only single valve involvement.
The offending microorganisms were the same as in the first
infection in 2 patients, different in 4, and culture negative in
3. Five patients underwent reoperation with 2 (40%) deaths,
and 4 patients were treated with antibiotics alone with 3
(75%) deaths. Freedom from recurrent endocarditis was
86% 7% at 5 years and 74% 5% at 10 years (Figure 2).
No predictors of recurrent endocarditis could be identified.
There were 8 reoperations: 5 for recurrent endocarditis, 2
for bioprosthetic valve degeneration, and 1 for valve dehis-
cence. Freedom from reoperation was 88% 9% at 5 years
and 73%  6% at 10 years (Figure 3).
Other valve-related complications were primary tissue
failure of bioprosthetic valves in 3 (2 were reoperated on),
valve dehiscence in 2 (1 underwent reoperation), and throm-
boembolic events in 2.
DISCUSSION
Infective endocarditis is a clinical challenge that is often
associated with a high morbidity and mortality.12 Despite
appropriate antibiotic use, surgical intervention is required
in 20% to 40% of cases.3,4 Echocardiography demonstrated
endocarditis on a single valve in most cases. The involve-
ment of two valves occurs much less frequently, and triple
or quadruple valve involvement is extremely uncommon.13
MVE is a separate clinical entity, which was recognized to
be an independent risk factor affecting survival in patients
with native or prosthetic endocarditis.14 The incidence of
MVE was 18% in the series reported by Kim and col-
leagues13 and 31% in that of David and colleagues.15 Inardiovascular Surgery c Volume 137, Number 6 1477
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Valves involved
TTE (n ¼ 48) TEE (n ¼ 22)
Intraoperative findings
(n ¼ 48)
MVE SVE Normal MVE SVE Normal MVE
MV and AV 21 9 10 13 4 1 40
AV and TV 0 1 0 1 0 0 1
AV and PV 0 2 0 1 0 0 2
PV and TV 0 2 0 0 0 0 2
MV, AV and PV 1 0 0 0 0 0 1
MV, AV, PV and TV 2 0 0 2 0 0 2
Total No. (%) 24 (50.0) 14 (29.2) 10 (20.8) 17 (77.3) 4 (18.2) 1 (4.5) 48 (100)
Data presented are number of patients (percentages in parentheses). MVE, Multivalvular endocarditis; TTE, transthoracic echocardiography; TEE, transesophageal echocardiog-
raphy; SVE, single valve endocarditis; MV, mitral valve; AV, aortic valve; TV, tricuspid valve; PV, pulmonary valve.our series, among 388 patients with documented infective
endocarditis reviewed, we found 48 (12.4%) patients who
had MVE. Streptococcus viridans was the most frequent
cause of native MVE in our patient population, which was
consistent with the report by Mihaljevic and colleagues16
but was different from the report by Kim and colleagues,13
TABLE 4. Operative data
Operative procedures
AVR and MVR 25
AVR and MVP 8
AVR and PVP 1
AVP and TVP 1
AVP and TVR 1
PVR and TVP 1
PVP and TVP 1
AVR and MVR with reconstruction of mitral annulus 4
Bentall and MVR with reconstruction of the
intervalvular fibrous body procedure
2
AVR and MVR with reconstruction of the
intervalvular fibrous body procedure
1
AVR, MVR, and PVP 1
AVR, MVR, PVP, and TVP 1
AVR, MVR, PVR, and TVR 1
Additional procedures
Repair of congenital VSD 5
Repair of congenital VSD and Valsalva aneurysm 2
Repair of congenital ASD 1
Repair of TOF 1
Repair of PDA 2
Repair of DCRVþPS 1
CABG 2
Aortic clamping time (mean  SD, min) 5828
Cardiopulmonary bypass time (mean  SD, min) 11329
Days in ICU (mean  SD) 7.43.7
Days in hospital (mean  SD) 19.58.3
AVR,Aortic valve replacement;MVR,mitral valve replacement;MVP,mitral valvulo-
plasty; PVP, pulmonary valvuloplasty; AVP, aortic valvuloplasty; TVP, tricuspid val-
vuloplasty; TVR, tricuspid valve replacement; PVR, pulmonary valve replacement;
VSD, ventricular septal defect; ASD, atrial septal defect; TOF, tetralogy of Fallot;
PDA, patent ductus arteriosus; DCRVþPS, double-chambered right ventricle and pul-
monary valve stenosis; CABG, coronary artery bypass grafting; SD, standard devia-
tion; ICU, intensive care unit.1478 The Journal of Thoracic and Cardiovascular Suin which the most common etiologic microorganism was
Staphyloccocus aureus.
The majority of patients with MVE had aortic and mitral
valve involvement, whereas triple or quadruple valve
involvement was rare. In patients with involvement of the
aortic and mitral valves, aortic valve endocarditis is gener-
ally thought to be the primary event. The most common
pathologic finding is aortic valve endocarditis with an asso-
ciated lesion on the anterior leaflet of the mitral valve. The
lesion may be a vegetation, aneurysm, or frank perforation.
The pathogenesis of the mitral valve lesion is thought to in-
volve a jet of aortic regurgitation that produces an infected
lesion on the anterior mitral leaflet. Other less common
mechanisms of anterior leaflet mitral valve involvement in
patients with aortic valve endocarditis include repeated im-
pingement of a prolapsing aortic vegetation on the anterior
mitral leaflet and direct extension of the infectious abscess
along the mitral–aortic intervalvular fibrous body.5 In the se-
ries reported by Kim and colleagues,13 all 14 cases involved
two valves and there were no cases of triple or quadruple
valve endocarditis. In our series, 1 patient had triple valve
endocarditis and 2 had quadruple valve endocarditis. MVE
with biventricular involvement is uncommon and is mainly
described in patients with prolonged intravenous infusions,
in patients addicted to intravenous drugs, or in patients
with CHD and a shunt.17 In our series, 6 patients had biven-
tricular involvement. All of them had predisposing CHD and
FIGURE 1. Long-term survival after valve surgery.rgery c June 2009
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persons with CHD are apt to receive their diagnosis at a later
age than those in developed countries. Inasmuch as many
people live in rural areas where poverty and lack of health
care is prevalent, it is not until endocarditis or other severe
complications develop that CHD is diagnosed. Biventricular
involvement of multiple valves in these patients can be
attributed to left-to-right ventricular communication. The in-
fection on one side of the heart could easily spread through
the left-to-right shunt produced by the CHD, thus affecting
valves on both sides of the heart.7
Demonstration of multivalvular involvement in patients
with suspected infective endocarditis is extremely impor-
tant. A finding of multiple valve lesions by any means
enables the identification of patients who are at higher risk
of complications, which, in turn, increases the ability to opti-
mally manage the patients. In these patients, any omission
will result in disastrous outcomes. In our opinion, two basic
principles are important for the successful demonstration of
MVE. First, the use of TEE is extremely helpful for demon-
stration of multivalvular involvement before surgery when
the TTE images are not optimal. The use of TEE increases
sensitivity and specificity to about 90%.18 Second, careful
intraoperative exploration plays a significant role in confirm-
ing the diagnosis ofMVE, especially in patients with risk fac-
tors such as severe aortic root abscess, predisposing CHD
with shunt, intravenous drug use, and so on. MVE was diag-
nosed preoperatively byTTE in only 50.0% of patients in our
series and by preoperative TEE in 77.3%. Fortunately,MVE
was confirmed through surgical exploration in all patients.
Although the need for operative repair in patients with
infective endocarditis is clear, the choice of valvular proce-
dure remains controversial.5 For patients with mitral valve
endocarditis, valvular replacement was proposed in the
mid-1960s, whereas more recently mitral valve repair has
become popular. In the meta-analysis by Feringa and co-
workers,19 mitral valve repair was associated with lower
in-hospital and long-term mortality, less repeat mitral valve
surgery during the early postoperative period and during
long-term follow-up, and fewer recurrent endocarditis and
FIGURE 2. Long-term freedom from endocarditis.The Journal of Thoracic and Ccerebrovascular events during long-term follow-up as com-
pared with patients who underwent mitral valve replace-
ment. Therefore, when feasible, mitral valve repair is
preferred for the surgical treatment of infective endocarditis
affecting the mitral valve. For aortic valve endocarditis, Ara-
nki and coworkers20 reported excellent results using stan-
dard prosthesis replacement. However, allograft aortic
valve replacement has distinct advantages, especially when
the aortic root is also involved. The homografts mold well
to the fragile infected aortic annulus, have good resistance
to infection, have excellent hemodynamic performance es-
pecially in small sizes, and do not require anticoagulation.21
The hospital mortality of 12.5% in this series compares fa-
vorably with that in Kim’s series13 andMihaljevic’s series,16
which reported operative mortalities of 21% and 16%, re-
spectively. In our series, patients with prosthetic valve endo-
carditis were not included and 33.3% of our patients had had
a previous episode of remote endocarditis. This patient mix
may be the main reason for the low hospital mortality in
this complex category of patients. Mihaljevic and col-
leagues16 found that the presence of an abscess at the time
of the operation was the only significant variable influencing
hospital mortality. In our series, however, the presence of
preoperative renal failure was found to be the most important
risk factor, with an odds ratio of 5.9, andNewYorkHeart As-
sociation class IV and emergency surgery were also identi-
fied as independent predictors for hospital mortality. The
overall survivals in our series at 5 and 10 years were 74%
and 62%, respectively, which were not substantially differ-
ent from those reported by Mihaljevic and colleagues16 of
87% and 64% at 5 and 10 years, respectively.
Operative mortality in patients with NVE ranges from 0%
to 10%. Late survival in these patients is good, with 5-year
survival of approximately 80% and 10-year survival of ap-
proximately 60%. Ten-year freedom from recurrent endo-
carditis after operation for NVE is approximately 80%.5
We present the largest series of these procedures from
China. In our study, hospital mortality was 12.5%, which
is similar to that for single valve endocarditis. Ten-year
survival was 73% and 10-year freedom from recurrent
FIGURE 3. Long-term freedom from reoperation.ardiovascular Surgery c Volume 137, Number 6 1479
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ported for single valve endocarditis. However, our results
could have been worse if we had had more patients with
acute endocarditis based on the fact that surgical treatment
and outcomes of patients with endocarditis are vastly differ-
ent depending on the acuity of their disease.
Several limitations are inherent to the present study. First,
this is a retrospective single-institution study. Second, this is
a clinical study of a relatively small number of patients. An-
other limitation is the long time period of the analysis;
changes in diagnostic criteria for NVE and surgical tech-
nique may influence outcome and prognostic factors. We
have started a prospective study of MVE at our institution
since 2007, and we will probably provide more convincing
conclusions in a few years.
In conclusion, MVE was diagnosed by TTE in only half
of affected patients at our institution. Intraoperative TEE
provided a more effective means to identify MVE. Radical
resection of all infected tissues for patients with MVE and
additional intraoperative interventions depending on the op-
erative pathologic status produced satisfactory in-hospital
and long-term results, similar to those in patients with a sin-
gle infected heart valve.
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